质亡:在肺癌中是一种新的治疗机制
Cheng Luo1,2, Xinhui Wu1,2, Shipeng Zhang1,2
1Chengdu University of Traditional Chinese Medicine, Chengdu, 610032, China.
Cancer cell international
|June 24, 2025
概括
铜依赖的细胞死亡过程 - - 质亡 (Cuproptosis) 显示出,通过向铜稳态来治疗肺癌具有前途. 诱导cuproptosis可能为这种致命疾病提供新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 肺癌是全球癌症相关死亡的主要原因之一.
- 细胞亡,一种独特的编程细胞死亡途径,与肺癌的发展和转移有关.
- 了解肺癌中cuproptosis机制对于开发新疗法至关重要.
研究的目的:
- 审查最近关于肺癌中铜恒温和铜的研究.
- 探索铜调和肺癌进展之间的联系.
- 确定潜在的治疗策略,以向肺癌中的cuproptosis.
主要方法:
- 通过科学网,PubMed和谷歌学者进行全面的文献搜索.
- 关键词: "cuproptosis" 和 "肺癌". 这两种疾病的症状是:
- 收录标准:2020年1月至2025年5月的出版物,重点关注亡机制和治疗剂.
主要成果:
- 肺癌患者表现出被破坏的铜平衡和抑制的亡.
- 关键蛋白质 (例如CTR1,ATP7A/B) 和基因 (例如FDX1,LIPT1) 在与肺癌相关的cuproptosis中至关重要.
- 埃莱斯克洛莫尔,迪苏尔菲拉姆和铜合剂等药物显示出诱导肺癌治疗中型亡的潜力.
- 肺癌细胞利用防御机制对抗铜的毒性.
结论:
- 型亡是一种新的依赖铜的细胞死亡机制,对肺癌有治疗意义.
- 铜代谢蛋白和基因的异常与肺癌的进展有关.
- 以铜为基础的疗法向cuproptosis为肺癌治疗提供了一个有希望的途径,可能改善患者的治疗结果.
相关概念视频
01:27Pneumothorax-II
388
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
388
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K